Novartis Products definition

Novartis Products means: (i) the Novartis Existing Products; (ii) the Novartis Future Products; and (iii) the Novartis Optional Products;
Novartis Products means, in respect of any territory, any Consumer Healthcare Products which are managed by the Novartis OTC Division and which have been reported for financial purposes in the OTC reporting segment of the Novartis Consumer Health Division in that territory for the year ended 31 December 2013 or since, an indicative list of which is set out in Schedule 9, Part 2;
Novartis Products. Goods produced, distributed, marketed or sold by the Seller or its Affiliates (other than the Business Products). "Novartis Sverige" As defined in Section 2.1(e). "Nutrition AB" As defined in the Preamble. "Nutrition AB Shares" As defined in Section 2.1(e). "Nutrition Brazil" A separate legal entity to be incorporated prior to Closing by the Seller in the Federative Republic of Brazil. "Nutrition Brazil Shares" As defined in Section 2.1(h). "Nutrition Canada" Novartis Nutrition Canada Inc. "Nutrition Canada Shares" As defined in Section 2.1(g). "Nutrition Corporation" As defined in the Preamble. "Nutrition Corporation Shares" As defined in Section 2.1(f). "Nutrition GmbH Austria" As defined in the Preamble. "Nutrition GmbH Austria Shares" As defined in Section 2.1(a). "Nutrition GmbH Germany" As defined in the Preamble. "Nutrition GmbH Germany Shares" As defined in Section 2.1(c). "Nutrition Italy" Novartis Medical Nutrition S.r.

Examples of Novartis Products in a sentence

  • In relation to affected Novartis Products that are either in stock or under the control of Licensee or any Affiliate of Licensee at the time of that termination or expiry, Licensee and its Affiliates may continue to sell those Novartis Products for a maximum period of six (6) months from the date of termination or expiry (as applicable), or any longer period that the Parties agree.

  • The Company did not acquire any employees, business pipeline, information technology systems, inventory nor any other tangible assets.In connection with the acquisition of the Novartis Products, and pursuant to the terms of the Asset Purchase Agreement, the Company concurrently entered into a license agreement with Novartis AG, Novartis Pharma AG and Novartis Pharmaceuticals Canada Inc.

  • The acquisition of the Novartis Products has been reflected in the unaudited pro forma condensed combined financial statements as being accounted for under the acquisition method in accordance with ASC 805, Business Combination, with Tribute treated as the accounting acquirer.

  • The Company concurrently entered into a supply agreement with Novartis Pharma AG (the “Supply Agreement”), pursuant to which Novartis Pharma AG agreed to supply the Company with the requirements of Novartis Products for sale for a transition period until the Company is able to transfer the marketing authorizations to the Company.

  • For purposes of these unaudited pro forma condensed combined financial information, we have not reflected the impact of the License Agreement or Supply Agreement.In connection with the acquisition the Company increased its existing debt facility with SWK by up to US$9.0 million, US$6.0 million of which was drawn upon in connection with the acquisition of the Novartis Products.

  • In connection with the acquisition the Company increased its existing debt facility with SWK by up to US$9.0 million, US$6.0 million ($6.7 million converted at a spot rate of $1.12 at September 30, 2014) of which was drawn upon in connection with the acquisition of the Novartis Products.

  • Pursuant to the terms of the License Agreement, the Novartis entities agreed to license to the Company certain assets relating to the Novartis Products, including certain intellectual property, marketing authorizations and related data, and medical, commercial and technical information (the “Licensed Assets”).

  • The audited statements of revenue and related expenses for the Novartis Products have been prepared in accordance with International Financial Reporting Standards as adopted by the International Accounting Standards Board (“IFRS”); we did not identify any material differences between the accounting policies used by Novartis Products under IFRS and U.S. GAAP.

  • In partial consideration of the license and rights granted under the Licensed Technology hereunder, Novartis shall pay ** percent ** royalties to Unigene on ** Net Sales of Other Novartis Products.

  • The historical results of Tribute and the Novartis Products have been derived from audited financial statements incorporated by reference and included elsewhere in this Form 8-K/A, respectively.


More Definitions of Novartis Products

Novartis Products means the pharmaceutical products listed in Part II of Schedule 3.
Novartis Products means the Products listed in Part II of Schedule 2 together with such additions as the Parties may agree in writing to add to the Collaboration from time to time;

Related to Novartis Products

  • Cannabis products means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Hemp products means all products made from industrial hemp,

  • Cannabis product means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Tobacco product manufacturer means an entity that after the date of enactment of this Act directly (and not exclusively through any affiliate):

  • New Products means any product which is not an Enhanced Product or 2 Existing Product but which is substantially similar to an Existing Product with respect to design and function and possesses reasonable performance improvements. If Company desires to purchase an Enhanced or New Product(s) from Supplier, Company shall so notify Supplier and provide Supplier the opportunity to manufacture such Enhanced or New Product(s), subject to the following conditions and procedures.

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • SAP Products means Software, Documentation, SAP Materials, Services, Subscription Services, Cloud Services and Maintenance Services. “SAP SDK” means SAP software development kit that includes tools such as APIs, source code, redistributable files and instructions. “Services” means SAP’s then-current services offered under and described in detail in the applicable SAP PartnerEdge Model.

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • processed products means goods placed under a processing procedure which have undergone processing operations;

  • Licensed producer means a person or entity licensed to produce medical cannabis.

  • Aerosol coating product means a pressurized coating product containing pigments or resins that dispenses product ingredients by means of a propellant, and is packaged in a disposable can for hand-held application, or for use in specialized equipment for ground traffic/marking applications.

  • Aerosol product means a pressurized spray system that dispenses product ingredients by means of a propellant contained in a product or a product's container, or by means of a mechanically induced force. “Aerosol Product” does not include “Pump Spray.”

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Marijuana products means concentrated marijuana products and marijuana products that are comprised of marijuana and other ingredients and are intended for use or consumption, such as, but not limited to, edible products, ointments, and tinctures.

  • Milk product or "dairy product" means cottage cheese, dry curd cottage cheese, reduced fat cottage cheese, lowfat cottage cheese, cream, light cream, light whipping cream, heavy cream, heavy whipping cream, whipped cream, whipped light cream, sour cream, acidified sour cream, cultured sour cream, half-and-half, sour half-and-half, acidified sour half-and-half, cultured sour half-and-half, reconstituted or recombined milk and milk products, concentrated milk, concentrated milk products, skim milk, lowfat milk, frozen milk concentrate, flavored milk, eggnog, buttermilk, cultured milk, cultured lowfat milk, cultured skim milk, yogurt, lowfat yogurt, nonfat yogurt, acidified milk, acidified lowfat milk, acidified skim milk, low-sodium milk, low-sodium lowfat milk, low-sodium skim milk, lactose-reduced milk, lactose-reduced lowfat milk, lactose-reduced skim milk, aseptically processed and packaged milk, milk products with added safe and suitable microbial organisms, and any other milk product made by the addition or subtraction of milkfat or addition of safe and suitable optional ingredients for protein, vitamin, or mineral fortification. Unless a product is considered a milk product under this subdivision, milk product does not include dietary products, infant formula, ice cream or other desserts, cheese, or butter. Milk products include the following:

  • Other Products means all products and services, other than an Advance, Credit Product or Derivative Transaction, offered by the Bank to any Obligor from time to time, including correspondent banking services, mortgage purchase programs and affordable housing and community investment products and services.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Third Party Products means the Third Party Software and Third Party Hardware.

  • Finished Products means the fully assembled and shrink-wrapped Licensed Products, each including a Game Cartridge, Game Cartridge label and Printed Materials.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Product Manufacturer means the entity that assembles the component parts to manufacture the final Product;

  • Competing Products means any product or service in existence or under development that competes with any product or service of the Company Group about which the Participant obtained Confidential Information or for which the Participant provided advisory services or had sales, origination, marketing, production, distribution, research or development responsibilities in the last twenty-four (24) months of employment with the Company Group.